Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Strong financial position with cash, cash equivalents and marketable securities of $91.5M as of December 2025 $2.25B Moderna global settlement for...

Strong financial position with cash, cash equivalents and marketable securities of $91.5M as of December 2025 $2.25B Moderna global settlement for infringement of lipid nanoparticle (LNP) delivery t… [+20336 chars]
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update - FHMnews